Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ciena | CIEN | 5. nov 2024 | 65.86 | +4.14 |
Cigna | CI | 5. nov 2024 | 318.39 | +1.94 |
Cimpress | CMPR | 5. nov 2024 | 76.43 | +3.77 |
Cincinnati Financial | CINF | 5. nov 2024 | 140.37 | +1.58 |
Cinemark | CNK | 5. nov 2024 | 29.69 | +0.41 |
Cineverse A | CNVS | 5. nov 2024 | 2.71 | -1.09 |
Cingulate | CING | 5. nov 2024 | 3.65 | -4.70 |
Cintas | CTAS | 5. nov 2024 | 208.99 | +0.69 |
Cion Investment | CION | 5. nov 2024 | 11.61 | +0.69 |
Cipher Mining | CIFR | 5. nov 2024 | 5.32 | +5.56 |
Cirrus Logic | CRUS | 5. nov 2024 | 102.79 | -7.09 |
Cisco Systems | CSCO | 5. nov 2024 | 56.16 | +0.59 |
CISO Global | CISO | 5. nov 2024 | 0.83 | +0.69 |
Citi Trends | CTRN | 5. nov 2024 | 19.38 | +1.73 |
Citigroup | C | 5. nov 2024 | 63.67 | +2.12 |
Citigroup Capital XIII Trust | C-N | 5. nov 2024 | 30.45 | +0.20 |
Citius Oncology | CTOR | 5. nov 2024 | 1.19 | 0.00 |
Citius Pharmaceuticals | CTXR | 5. nov 2024 | 0.35 | +0.20 |
Citizens & Northern | CZNC | 5. nov 2024 | 19.08 | +1.17 |
Citizens A | CIA | 5. nov 2024 | 4.95 | +0.41 |
Citizens Community Bancorp | CZWI | 5. nov 2024 | 14.00 | -0.36 |
Citizens Financial Group | CFG | 5. nov 2024 | 42.22 | +1.51 |
Citizens Financial Group D Pref | CFG-D | 5. nov 2024 | 24.99 | 0.00 |
Citizens Financial Group E Pref | CFG-E | 5. nov 2024 | 21.78 | +1.59 |
Citizens Financial Group Pref H | CFG-H | 5. nov 2024 | 27.41 | +0.48 |
Citizens Financial Services | CZFS | 5. nov 2024 | 62.37 | +5.28 |
City Holding | CHCO | 5. nov 2024 | 118.29 | +2.66 |
City Office REIT | CIO | 5. nov 2024 | 5.28 | +3.13 |
City Office REIT A Pref | CIO-A | 5. nov 2024 | 17.50 | 0.00 |
Civeo | CVEO | 5. nov 2024 | 25.17 | +1.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.